RxDoctor Payments DataLook up a doctor →

Clint Mower

Family Medicine · Lehi, UTNPI 1437653854

Payments from drug & device makers

$41,347in general payments, 2019–2025

Across 338 payments — averaging $122.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$37K
  • AbbVie$1K
  • AstraZeneca$218
  • Lilly USA, LLC$199
  • Corcept Therapeutics$173
  • Novo Nordisk$172
  • plus $2K from 44 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson92$37,073
AbbVie80$1,229
AstraZeneca15$218
Lilly USA, LLC12$199
Corcept Therapeutics5$173
Novo Nordisk11$172
Boehringer Ingelheim8$169
Corium, LLC9$169
Tris Pharma Inc8$151
Amgen9$144
Axsome Therapeutics, Inc.6$130
Lucid Diagnostics Inc.2$107
Dynavax Technologies Corporation4$102
Pfizer6$93
Sanofi-aventis U.S. LLC6$90
Mylan Specialty L.p.3$76
Bayer4$73
Phathom Pharmaceuticals, Inc.4$66
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC4$63
Janssen Scientific Affairs, LLC1$60
Edwards Lifesciences3$57
Ironshore Pharmaceuticals Inc.3$54
Idorsia Pharmaceuticals US Inc3$49
Avanir Pharmaceuticals, Inc.3$47
Dexcom, Inc.2$46
Supernus Pharmaceuticals, Inc.3$45
Vanda Pharmaceuticals Inc.1$35
Almatica Pharma LLC2$31
Kowa Pharmaceuticals America, Inc.2$30
Organon4$30
Novartis2$28
Antares Pharma, Inc.2$28
GSK2$25
Ascendis Pharma Endocrinology Inc1$22
Xeris Pharmaceuticals, Inc.1$22
Biohaven Pharmaceutical Holding Company Ltd.1$20
Medtronic1$20
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$19
Boston Scientific1$18
Collegium Pharmaceutical, Inc.1$17
Hologic Sales And Service, LLC1$16
Cranial Technologies, Inc1$15
Nestle Healthcare Nutrition Inc.1$15
Otsuka America Pharmaceutical, Inc.1$15
Ultragenyx Pharmaceutical Inc.1$15
BD1$14
Takeda Pharmaceuticals U.S.A., Inc.1$14
Currax Pharmaceuticals LLC1$14
Exact Sciences1$13
Merck1$13

How this compares

$41,347 in reported general payments places this provider in the 90th percentile of 928 family medicine providers in Utah.

See all family medicine providers in Utah →

Medicare billing

Part B allowed, 2024
$36,455
Medicare patients
126
Services billed
650

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Lehi

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →